Condition: Patient With Radiotherapy (Linac MRI) · Mobile Cancerous Lesion · Sponsor: Centre Georges Francois Leclerc
The patients eligible for the study are those treated by radiotherapy on Linac MRI for a mobile cancerous lesion (pancreas, liver, kidneys, adrenals, lung, adenopathy above or below the diaphragm ...). After signing the consent form, each patient will be randomized to one of two treatment arms: * Standard arm : Radiotherapy treatment with Linac MRI without non-magnetic shielding * Experimental arm : radiotherapy treatment with Linac MRI with non-magnetic screen The aim is to evaluate the effect of using a non-magnetic screen visible to the patient in the bunker during radiotherapy sessions delivered by Linac MRI on decreasing the ratio between the actual treatment time and the treatment time predicted by the machine.
This description comes directly from the study's public registry record.
Gilles TRUC, Doctor · 03 80 73 75 18 · gtruc@cgfl.fr
Sophie PARNALLAND, Project Manager · 03 45 34 80 77 · sparnalland@cgfl.fr
Always discuss trial participation with your own doctor first.
| Centre Georges-François Leclerc | Dijon, Côte d'Or, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05783908